Repare Therapeutics Inc.
- Jurisdiction
Canada - ISIN
US7602731025 (RPTX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. Read full profile
Fundamentals
- Net revenue
-€45.40M - Gross margin
98.1% - EBIT
-€98.94M - EBIT margin
217.9% - Net income
-€93.71M - Net margin
206.4%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Cathie Wood |
|
|
|
Sell |
| Peter Brown |
|
|
|
Sell |